Real-World Data: The Cornerstone of Life Science Consulting Life sciences are at an inflection point. As pressure mounts to develop therapies faster, prove real-world value to payers, and personalize interventions, traditional data sources are hitting their limits. Real-world data (RWD), particularly claims data, has emerged as a critical lever across the product lifecycle. For consultancies,…

Why Real-World Evidence Matters Beyond Clinical Trials Market access has never been more complex than it is right now. In a world where payers are tightening the purse strings and every therapeutic area feels like a battleground, just getting a therapy onto formulary, or getting a diagnostic test approved isn’t enough. You need to prove…

Gram-negative bacteria. The very name can send shivers down the spines of healthcare professionals. These microorganisms, characterized by their complex cell wall structure, are increasingly developing resistance to even our strongest antibiotics.  If bacterial infections in general are a concern, gram-negative bacteria are particularly challenging – since even minor infections can become life-threatening when they…